A Randomized Double-Blind Comparative Study of Sublingual Immunotherapy for Cedar Pollinosis

Kimihiro Okubo, Minoru Gotoh, Shigeharu Fujieda, +6

Allergology International

Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet

Minoru Gotoh, Syuji Yonekura, Toru Imai, +5

The Journal of Allergy and Clinical Immunology In Practice

AsthmaLong-term EfficacyAllergy MedicineImmunologyPeanut Allergy +6

Epidemiological Survey of Allergic Rhinitis in Japan 2019

Atsushi Matsubara, Masafumi Sakashita, Minoru Gotoh, +9

Nippon Jibiinkoka Gakkai Kaiho

AllergyAllergy MedicineClinical EpidemiologyPublic HealthAllergic Rhinitis +2

Fexofenadine Improves the Quality of Life and Work Productivity in Japanese Patients with Seasonal Allergic Rhinitis during the Peak Cedar Pollinosis Season

Kimihiro Okubo, Minoru Gotoh, Kenichi Shimada, +3

International Archives of Allergy and Immunology

Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets

Syuji Yonekura, Minoru Gotoh, Shinya Kaneko, +3

The Journal of Allergy and Clinical Immunology In Practice

Mechanisms of IL-6, IL-8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge.

K Ohkubo, Masakazu Ikeda, Ruby Pawankar, +3

PubMed

AsthmaEnvironmental AllergyNasal MucosaInflammatory Lung DiseaseAllergy Medicine +18

Effects of<i>Lactobacillus gasseri</i>OLL2809 and α-lactalbumin on university-student athletes: a randomized, double-blind, placebo-controlled clinical trial

Toshihiro Sashihara, Masashi Nagata, Takeshi Mori, +5

Applied Physiology Nutrition and Metabolism

NutritionUniversity-student AthletesPhysical ActivityProbioticFatigue Management +18

Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet

Minoru Gotoh, Kimihiro Okubo, Atsushi Yuta, +27

Allergology International

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Kimihiro Okubo, Minoru Gotoh, Mikiya Asako, +5

Allergology International

Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons

Syuji Yonekura, Minoru Gotoh, Shinya Kaneko, +4

Allergology International